Stephanie Pearl
Corporate Officer/Principal bij Office of Technology Development
Profiel
Prior to joining OTD, Stephanie was a Senior Clinical Research Contracts Associate at Dana-Farber Cancer Institute where she focused on all contractual matters associated with industry sponsored and industry supported clinical trials and related research.
Prior to joining academia, Stephanie served as Legal Counsel for several pharma/biotech companies.
Stephanie holds a Common Law degree from University of Ottawa, a Civil Law degree from the Université de Montreal and a B.Sc.
in Nutritional Sciences from McGill University.
Actieve functies van Stephanie Pearl
| Bedrijven | Functie | Begin |
|---|---|---|
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | - |
Eerdere bekende functies van Stephanie Pearl
| Bedrijven | Functie | Einde |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Consultant / Adviseur | 30-11-2007 |
| PFIZER, INC. | Consultant / Adviseur | 31-08-2003 |
Opleiding van Stephanie Pearl
| University of Ottawa | Undergraduate Degree |
| University of Montréal | Undergraduate Degree |
| McGill University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Finance |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
